Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | CHRNB2 | P17787 | 6/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 6/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.41 |
| ▸ | KHK | P50053 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | HTR7 | P34969 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2489674 | 0.99 | ADRB1 (0.52) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL27107055 | 0.92 | ADRB1 (0.63) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL2304941 | 0.83 | IP6K1 (0.59) | ALDH1A1TSHRHSD17B10IP6K1KDM4E | |
| SCHEMBL30798753 | 0.79 | ADRB1 (0.61) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL1741562 | 0.79 | ADRB1 (0.61) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL5231120 | 0.78 | ADRB1 (0.86) | ADRB1CHRNB2CHRNA4CHRNA1CHRNA7 | |
| SCHEMBL334256 | 0.77 | ALDH1A1 (0.64) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL15547292 | 0.77 | ADRB1 (0.58) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL13460161 | 0.76 | IP6K1 (0.49) | ADRB1ALDH1A1USP2TSHRHSD17B10 | |
| SCHEMBL1336438 | 0.76 | CHEK1 (0.51) | IP6K1KDM4EMAPTKMT2AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122005879-A | Modified GRPR antagonist peptides for cancer imaging and treatment | 慕尼黑工业大学 | 2026-05-12 | — | — | CN | claimed |
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | UNIV MUENCHEN TECH (DE) | 2026-01-22 | — | — | US | claimed |
| EP-4651910-A1 | DUAL LABELLED COMPOUNDS TARGETING THE PROSTATE SPECIFIC MEMBRANE ANTIGEN | Centre Hospitalier Universitaire Vaudois (CHUV) (CH) | 2025-11-26 | — | — | EP | claimed |
| US-12419976-B2 | Hybrid tracers for targeted cancer imaging and treatment | ACADEMISCH ZIEKENHUIS LEIDEN (H.O.D.N. LUMC) GMBH (NL) | 2025-09-23 | — | — | US | claimed |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2025-09-18 | — | — | US | claimed |
| US-12390540-B2 | Dual mode radiotracer and -therapeutics | Technische Universität München (DE) | 2025-08-19 | — | — | US | claimed |
| EP-4291250-B1 | DUAL MODE RADIOTRACER AND THERAPEUTICS | UNIV MUENCHEN TECH (DE) | 2025-01-15 | — | — | EP | claimed |
| US-20240399001-A1 | RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP) | Blue Earth Diagnostics Limited (GB) | 2024-12-05 | — | — | US | claimed |
| US-20240366811-A1 | RADIONUCLIDE LABELED POLYPEPTIDE CONJUGATES AND USES THEREOF | TIANJIN CONJUSTAR BIOLOGICS CO., LTD. (CN) | 2024-11-07 | — | — | US | claimed |
| WO-2024222840-A1 | NOVEL RADIONUCLIDE-LABELED POLYPEPTIDE CONJUGATE AND USE THEREOF | 天津星联肽生物科技有限公司 | 2024-10-31 | — | — | WO | claimed |
| EP-4043041-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München (DE) | 2022-08-17 | — | — | EP | claimed |
| US-20220118120-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | Technische Universität München (DE) | 2022-04-21 | — | — | US | claimed |
| WO-2022018264-A1 | SILICON-CONTAINING LIGAND COMPOUNDS | Technische Universität München (DE) | 2022-01-27 | — | — | WO | claimed |
| EP-3917582-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | Technische Universität München (DE) | 2021-12-08 | — | — | EP | claimed |
| CN-113573743-A | Diagnostic imaging agents for cancer | 慕尼黑工业大学 | 2021-10-29 | — | — | CN | claimed |
| WO-2021116712-A1 | FUNCTIONALISED MICROBUBBLE MEDIATED CELL TAGGING | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2021-06-17 | — | — | WO | claimed |
| WO-2020157184-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | Technische Universität München (DE) | 2020-08-06 | — | — | WO | claimed |
| US-20200197545-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | TECHNISCHE UNIVERSITÄT MÜNCHEN - KLINIKUM RECHTS DER ISAR (DE) | 2020-06-25 | — | — | US | claimed |
| CN-111132700-A | Dual-mode radiotracer and therapeutic agent | 慕尼黑工业大学 | 2020-05-08 | — | — | CN | claimed |
| US-20070184537-A1 | Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides | PAUL SCHERRER INSTITUT (CH) | 2007-08-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12419976-B2 | Hybrid tracers for targeted cancer imaging and treatment | HNRNPF, ANXA3, SLC67A1 | ADRB1 878/4885ALDH1A1 2468/4885USP2 3741/4885 |
| US-20240366811-A1 | RADIONUCLIDE LABELED POLYPEPTIDE CONJUGATES AND USES THEREOF | GRPR, SSTR4, DNPEP | ADRB1 3114/4885ALDH1A1 4072/4885USP2 3148/4885 |
| US-20260021211-A1 | Dual mode radiotracer and -therapeutics | FOLH1, SLC19A1, KLK3 | ADRB1 3419/4885ALDH1A1 2663/4885USP2 4302/4885 |
| US-20240399001-A1 | RADIOTRACERS AND THERAPEUTICS BINDING TO FIBROBLAST ACTIVATION PROTEIN (FAP) | FAP, FIBP, FGFR1 | ADRB1 4618/4885ALDH1A1 1672/4885USP2 3557/4885 |
| US-20250288704-A1 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | CXCR4, CXCR1, CXCR3 | ADRB1 231/4885ALDH1A1 1193/4885USP2 4548/4885 |
| US-20200197545-A1 | DUAL MODE RADIOTRACER AND -THERAPEUTICS | SSTR2, SSTR1, PAICS | ADRB1 4453/4885ALDH1A1 3352/4885USP2 4016/4885 |
| US-20070184537-A1 | Method for the linkage of bifunctional chelating agents and (radioactive) transition metal complexes to proteins and peptides | EPRS1, SLC7A11, QPCTL | ADRB1 4859/4885ALDH1A1 4546/4885USP2 1533/4885 |
| US-12390540-B2 | Dual mode radiotracer and -therapeutics | PAICS, SSTR2, SSTR1 | ADRB1 4438/4885ALDH1A1 3163/4885USP2 4166/4885 |
| US-20220118120-A1 | CANCER DIAGNOSTIC IMAGING AGENTS | FOLH1, FOLR1, KLK3 | ADRB1 4410/4885ALDH1A1 1382/4885USP2 4108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.